DGIST researchers developed a deep learning model that classifies lung cancer exosomes based on physical properties measured by atomic force microscopy.
Key Details
- 1DGIST team used AFM to measure nanomechanical properties (stiffness, height-to-radius) of exosomes from NSCLC cell lines with different genetic mutations.
- 2AI model (DenseNet-121) classified exosomes by origin, achieving 96% accuracy and AUC of 0.92.
- 3Exosome stiffness reflected KRAS and EGFR mutations in their respective lung cancer cell lines.
- 4The method enables high-precision, label-free, liquid biopsy-based lung cancer diagnosis.
- 5Study published July 8, 2025, in Analytical Chemistry.
Why It Matters
This approach could offer a rapid, non-invasive way to diagnose lung cancer genetic mutations, reducing the need for tissue biopsies. Leveraging AI with nanomechanical imaging pushes boundaries in early cancer detection and personalized medicine.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.